跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 36 条关于
“TEAD1”
全部
36
临床试验
2
药物
26
机构
0
资讯
8
2年前
IAG933, a Novel YAP/TAZ-TEAD Inhibitor, Shows Promise in Preclinical Cancer Models
去年
UTR Therapeutics Submits IND for Novel mRNA-Destabilizing Drug Targeting c-MYC in Multiple Cancers
4年前
First Patient Dosed in Trial of TEAD Inhibitor for Advanced Solid Tumors
23天前
Vivace Therapeutics Advances VT3989, First TEAD Inhibitor, Toward Pivotal Phase 3 Trial in Mesothelioma
3个月前
XtalPi's AI-Designed Peptide Receives US Safety Certification While Pan-TEAD Inhibitor Advances to Clinical Trials
11个月前
BridGene Biosciences Secures $28 Million Series B+ Funding to Advance TEAD Inhibitor BGC-515 Toward Phase 2
去年
Relay Therapeutics' RLY-2608: A Mutant-Selective PI3Kα Inhibitor Enters Phase I Trials for HR+/HER2- Breast Cancer
上个月
Insilico Medicine to Present First-in-Human Phase 1 Data for AI-Designed Pan-TEAD Inhibitor ISM6331 at ESMO 2026